Results 81 to 90 of about 135,140 (306)
Кардиоваскулярная терапия и профилактика, 2005 Aim. To assess factors influencing the long-term results of valve prosthetic surgery in heart valve disease. Material and methods. In total, 310 patients with heart valve surgery in anamnesis were examined: 168 females (54%), 142 males (46%); mean age 54.
L. I. Murzabekova, V. A. Orlov
doaj
Frontiers in Cardiovascular Medicine, 2022 BackgroundInfective endocarditis is a complication with high mortality in patients with congenital heart disease, particularly for those with bioprosthetic valve.Case summaryWe report a case of a 54-year-old female with a history of tetralogy of Fallot ...
Yan-Jie Li, Xin Pan, Cheng Wang, Ben He
doaj +1 more source
An Ultrathin and Lightweight Soft Inflatable Actuator for Natural Tactile Sensory Feedback
Advanced Intelligent Systems, EarlyView.A lightweight, ultrathin soft actuator mimics natural touch by delivering strong, multimodal haptic feedback through pressure and vibration. Tested on both able‐bodied individuals and amputees, it achieves high sensory precision in a compact form. Its simplicity, power, and adaptability hint at transformative applications in prosthetics, immersive ...
Hanna Scherer +7 more
wiley +1 more source
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]
, 2012 Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Beiras Fernández, Andrés +6 more
core +2 more sources
Bioprosthetic Aortic Valve Replacement in <50 Years Old Patients – Where is the Evidence?
Brazilian Journal of Cardiovascular Surgery, 2019 Aortic valve disease is one of the most common valvular heart diseases in the cardiovascular category. Surgical replacement of the diseased aortic valve remains the definitive intervention for most diseases.
Amer Harky +4 more
doaj +1 more source
Clinical Case Reports, 2021 We evaluated early outcomes of transcatheter valve‐in‐valve (ViV) implantation in patients with degenerated bio‐prosthesis in tricuspid position. Total of 5 patients were included in our case series.
Mann Chandavimol +7 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Transcatheter aortic valve implantation (TAVI) has changed the treatment of aortic stenosis. The Myval transcatheter heart valve (THV), a novel balloon‐expandable THV, has shown promising outcomes. Our aim is to compare the comparative safety and effectiveness of Myval THV against established THVs, such as Sapien and Evolut.
Anastasios Apostolos +8 more
wiley +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular DiseaseBackground It remains controversial whether prosthesis‐patient mismatch (PPM) impacts long‐term outcomes after surgical aortic valve replacement.
M. P. Sá +8 more
semanticscholar +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan +3 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Aims Valve degeneration after DirectFlow implantation poses a challenge for valve‐in‐valve procedures due to its fragile polymeric structure and embolization risk. This study analyzes long‐term follow‐up of patients who underwent TAVI with DF to understand valve degeneration tendencies.
Dan M. Prunea +11 more
wiley +1 more source